MedTrace Logo

Trans-perineal Ultrasound in Assessment of PPROMs

NCT06443788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-06-12

No results posted yet for this study

Summary

Accurate and timely diagnosis of preterm pre-labor rupture of membranes (PPROM) is important to prevent adverse maternal and fetal outcomes. Following a history of PPROM, physical examination should be performed in a way that minimizes the risk of infection using a speculum. This is important to confirm the diagnosis by visualizing the amniotic fluid passing from the cervical canal or pooling in the vagina. In addition to examining the cervix to assess its dilatation and effacement and look for umbilical cord prolapse or fetal prolapse. However, Pelvic exam is one of the most common anxiety provoking medical procedures that's why this study aims at using the transperineal ultrasound as a non-invasive, accurate, cost effective, applicable and readily available tool in assessment of PPROM with less patient anxiety and fear.

Conditions

  • PPROM
  • Preterm Premature Rupture of Membrane

Interventions

DIAGNOSTIC_TEST

transperineal ultrasound

The following measurement will be recorded: 1. Amniotic fluid pooling assessment will be performed in sagittal and transverse planes. , * Images will be evaluated for appearance of accumulated hypoechogenic fluid around cervix. Whenever collection is spotted, three largest dimensions of fluid will be measured (length, width, depth). * Fluid accumulations around the cervix that are clearly demarcated from surrounding tissues will be considered positive. 2. Cervical length: it will be measured between the internal os point to the external os point below. Cervical dilatation will be measured in a transverse plane from inner to inner. 3. Presence of fetal part prolapse and/or cord prolapse

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Maya M. Abdelrazek, MD · Ain Shams University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-02-01
Completion
2025-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06443788 on ClinicalTrials.gov